Cyclooxygenase knockout mice
Tóm tắt
Từ khóa
Tài liệu tham khảo
DeWitt, 1988, Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence, Proc Natl Acad Sci USA, 85, 1412, 10.1073/pnas.85.5.1412
Merlie, 1988, Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase), J Biol Chem, 263, 3550, 10.1016/S0021-9258(18)68959-8
O’Banion, 1991, A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein, J Biol Chem, 266, 23261, 10.1016/S0021-9258(18)54491-4
Kujubu, 1991, TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue, J Biol Chem, 266, 12866, 10.1016/S0021-9258(18)98774-0
Xie, 1991, Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing, Proc Natl Acad Sci USA, 88, 2692, 10.1073/pnas.88.7.2692
Sirois, 1992, Hormonal regulation of messenger ribonucleic acid encoding a novel isoform of prostaglandin endoperoxide H synthase in rat preovulatory follicles. Induction in vivo and in vitro, J Biol Chem, 267, 11586, 10.1016/S0021-9258(19)49951-1
Smith, 1996, Prostaglandin endoperoxide H synthases-1 and -2, Adv Immunol, 62, 167, 10.1016/S0065-2776(08)60430-7
Smith, 1993, Differentiation of monocytoid THP-1 cells with phorbol ester induces expression of prostaglandin endoperoxide synthase-1 (COX-1), Biochem Biophys Res Commun, 192, 787, 10.1006/bbrc.1993.1483
Jackson, 1993, Effects of transforming growth factor-β and interleukin-1 β on expression of cyclooxygenase 1 and 2 and phospholipase A2 mRNA in lung fibroblasts and endothelial cells in culture, Biochem Biophys Res Commun, 197, 1465, 10.1006/bbrc.1993.2642
Samet, 1995, Selective induction of prostaglandin G/H synthase I by stem cell factor and dexamethasone in mast cells, J Biol Chem, 270, 8044, 10.1074/jbc.270.14.8044
Brannon, 1994, Prostacyclin synthesis in ovine pulmonary artery is developmentally regulated by changes in cyclooxygenase-1 gene expression, J Clin Invest, 93, 2230, 10.1172/JCI117220
Yamagata, 1993, Expression of a mitogen-inducible cyclooxygenase in brain neurons, Neuron, 11, 371, 10.1016/0896-6273(93)90192-T
Walenga, 1996, Constitutive expression of prostaglandin endoperoxide G/H synthetase (PGHS)-2 but not PGHS-1 in human tracheal epithelial cells in vitro, Prostaglandins, 52, 341, 10.1016/S0090-6980(96)00101-3
Harris, 1994, Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction, J Clin Invest, 94, 2504, 10.1172/JCI117620
Morita, 1995, Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2, J Biol Chem, 270, 10902, 10.1074/jbc.270.18.10902
Smith, 1996, Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2, J Biol Chem, 271, 33157, 10.1074/jbc.271.52.33157
Negishi, 1995, Molecular mechanisms of diverse actions of prostanoid receptors, Biochim Biophys Acta, 1259, 109, 10.1016/0005-2760(95)00146-4
Brun, 1996, Differential activation of adipogenesis by multiple PPAR isoforms, Genes Dev, 10, 974, 10.1101/gad.10.8.974
Kliewer, 1997, Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ, Proc Natl Acad Sci USA, 94, 4318, 10.1073/pnas.94.9.4318
Reddy, 1997, Prostaglandin synthase-1 and prostaglandin synthase-2 are coupled to distinct phospholipases for the generation of prostaglandin D2 in activated mast cells, J Biol Chem, 272, 3231, 10.1074/jbc.272.6.3231
Vane, 1971, Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs, Nat New Biol, 231, 232, 10.1038/newbio231232a0
Xie, 1992, Mitogen-inducible prostaglandin G/H synthase, Drug Dev Res, 25, 249, 10.1002/ddr.430250402
Meade, 1993, Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs, J Biol Chem, 268, 6610, 10.1016/S0021-9258(18)53294-4
Mitchell, 1994, Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells, Br J Pharmacol, 113, 1008, 10.1111/j.1476-5381.1994.tb17093.x
Masferrer, 1996, Cyclooxygenase-2 inhibitors, Gastroenterol Clin North Am, 25, 363, 10.1016/S0889-8553(05)70252-1
Kalgutkar, 1998, Aspirin-like molecules that covalently inactivate cyclooxygenase-2, Science, 280, 1268, 10.1126/science.280.5367.1268
Vane, 1998, Mechanism of action of nonsteroidal anti-inflammatory drugs, Am J Med, 104, 2S, 10.1016/S0002-9343(97)00203-9
Smith, 1998, Pharmacological analysis of cyclooxygenase-1 in inflammation, Proc Natl Acad Sci USA, 95, 13313, 10.1073/pnas.95.22.13313
Abramson, 1989, The mechanisms of action of nonsteroidal antiinflammatory drugs, Arthritis Rheum, 32, 1, 10.1002/anr.1780320102
Alberts, 1995, Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase?, J Cell Biochem Suppl, 22, 18, 10.1002/jcb.240590804
Hanif, 1996, Staiano Coico L, Shiff SI and Rigas B, Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway, Biochem Pharmacol, 52, 237, 10.1016/0006-2952(96)00181-5
Piazza, 1997, Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels, Cancer Res, 57, 2909
Piazza, 1997, Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction, Cancer Res, 57, 2452
Wechter, 1997, R-Flurbiprofen chemoprevention and treatment of intestinal adenomas in the APCMin/+ mouse model, Cancer Res, 57, 4316
Lehmann, 1997, Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs, J Biol Chem, 272, 3406, 10.1074/jbc.272.6.3406
Elder, 1997, Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug, Clin Cancer Res, 3, 1679
Langenbach, 1995, Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin- induced gastric ulceration, Cell, 83, 483, 10.1016/0092-8674(95)90126-4
Morham, 1995, Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse, Cell, 83, 473, 10.1016/0092-8674(95)90125-6
Dinchuk, 1995, Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II, Nature, 378, 406, 10.1038/378406a0
Marnett, 1992, Aspirin and the potential role of prostaglandins in colon cancer, Cancer Res, 52, 5575
Prescott, 1996, Self-promotion? Intimate connections between APC and prostaglandin H synthase-2, Cell, 87, 783, 10.1016/S0092-8674(00)81983-2
Herschman, 1996, Prostaglandin synthase 2, Biochim Biophys Acta, 1299, 125, 10.1016/0005-2760(95)00194-8
Williams, 1996, Prostaglandin endoperoxide synthase, Am J Physiol, 270, G393
Wallace, 1997, Nonsteroidal anti-inflammatory drugs and gastroenteropathy, Gastroenterology, 112, 1000, 10.1053/gast.1997.v112.pm9041264
Mahler, 1996, Disruption of cyclooxygenase genes in mice, Toxicol Pathol, 24, 717, 10.1177/019262339602400607
Robert, 1979, Cytoprotection by prostaglandins, Gastroenterology, 77, 761, 10.1016/0016-5085(79)90235-X
Black, 1986, Renal toxicity of non-steroidal anti-inflammatory drugs, Toxicol Pathol, 14, 83, 10.1177/019262338601400110
Lichtenstein, 1995, Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword, Arthritis Rheum, 38, 5, 10.1002/art.1780380103
Murray, 1993, Renal toxicity of the nonsteroidal anti-inflammatory drugs, Annu Rev Pharmacol Toxicol, 33, 435, 10.1146/annurev.pa.33.040193.002251
Pairet, 1996, Distinct isoforms (COX-1 and COX-2) of cyclooxygenase, Fundam Clin Pharmacol, 10, 1, 10.1111/j.1472-8206.1996.tb00144.x
Wilson, 1991, Role of prostaglandins in gastroduodenal mucosal protection, J Clin Gastroenterol, 13, S65, 10.1097/00004836-199112001-00011
Funk, 1991, Human platelet/erythroleukemia cell prostaglandin G/H synthase, FASEB J, 5, 2304, 10.1096/fasebj.5.9.1907252
Whelton, 1995, Renal effects of over-the-counter analgesics, J Clin Pharmacol, 35, 454, 10.1002/j.1552-4604.1995.tb04088.x
Rao, 1995, Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent, Cancer Res, 55, 1464
Thun, 1991, Aspirin use and reduced risk of fatal colon cancer, N Engl J Med, 325, 1593, 10.1056/NEJM199112053252301
Thun, 1993, Aspirin use and risk of fatal cancer, Cancer Res, 53, 1322
Verma, 1980, Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate, Cancer Res, 40, 308
Fürstenberger, 1989, Eicosanoids and multistage carcinogenesis in NMRI mouse skin, Carcinogenesis, 10, 91, 10.1093/carcin/10.1.91
Muller-Decker, 1995, Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis, Mol Carcinog, 12, 31, 10.1002/mc.2940120106
Sano, 1995, Expression of cyclooxygenase-1 and -2 in human colorectal cancer, Cancer Res, 55, 3785
Eberhart, 1994, Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas, Gastroenterology, 107, 1183, 10.1016/0016-5085(94)90246-1
Dubois, 1996, Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors, Gastroenterology, 110, 1259, 10.1053/gast.1996.v110.pm8613017
Boolbol, 1996, Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis, Cancer Res, 56, 2556
Kargman, 1995, Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer, Cancer Res, 55, 2556
Oshima, 1996, Suppression of intestinal polyposis in ApcΔ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2), Cell, 87, 803, 10.1016/S0092-8674(00)81988-1
Oshima, 1995, Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene, Proc Natl Acad Sci USA, 92, 4482, 10.1073/pnas.92.10.4482
Chulada, 1998, Cyclooxygenase-1 and -2 deficiency decrease spontaneous intestinal adenomas in the Min mouse, Proc Am Assoc Cancer Res, 39, 195
Moser, 1990, A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse, Science, 247, 322, 10.1126/science.2296722
Shoemaker, 1997, Studies of neoplasia in the Min mouse, Biochim Biophys Acta, 1332, F25
Reddy, 1993, Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats, Carcinogenesis, 14, 1493, 10.1093/carcin/14.8.1493
Boutwell, 1974, The function and mechanism of promoters of carcinogenesis, CRC Crit Rev Toxicol, 2, 419, 10.3109/10408447309025704
Tiano, 1998, Effects of cyclooxygenase deficiency on inflammation and papilloma formation in mouse skin, Proc Am Assoc Cancer Res, 38, 257
Jang, 1997, Cancer chemopreventive activity of resveratrol, a natural product derived from grapes, Science, 275, 218, 10.1126/science.275.5297.218
Muller-Decker, 1998, Localization of prostaglandin H synthase isoenzymes in murine epidermal tumors, Mol Carcinog, 23, 36, 10.1002/(SICI)1098-2744(199809)23:1<36::AID-MC5>3.0.CO;2-F
Tsujii, 1995, Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2, Cell, 83, 493, 10.1016/0092-8674(95)90127-2
Tsujii, 1998, Cyclooxygenase regulates angiogenesis induced by colon cancer cells, Cell, 93, 705, 10.1016/S0092-8674(00)81433-6
Narko, 1997, Tumorigenic transformation of immortalized ECV endothelial cells by cyclooxygenase-1 overexpression, J Biol Chem, 272, 21455, 10.1074/jbc.272.34.21455
Chiu, 1997, Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis, Cancer Res, 57, 4267
Lim, 1997, Multiple female reproductive failures in cyclooxygenase 2-deficient mice, Cell, 91, 197, 10.1016/S0092-8674(00)80402-X
Richards, 1997, Sounding the alarm—Does induction of prostaglandin endoperoxide synthase-2 control the mammalian ovulatory clock?, Endocrinology, 138, 4047, 10.1210/endo.138.10.5515
Challis, 1997, Prostaglandins and reproduction—What do knockouts really tell us?, Nat Med, 3, 1326, 10.1038/nm1297-1326
Davis, 1999, Anovulation in cyclooxygenase-2 deficient mice is restored by prostaglandin E2 and interleukin-1β, Endocrinology, 140, 2685, 10.1210/endo.140.6.6715
Gross, 1998, Opposing actions of prostaglandins and oxytocin determine the onset of murine labor, Proc Natl Acad Sci USA, 95, 11875, 10.1073/pnas.95.20.11875
Sugimoto, 1997, Failure of parturition in mice lacking the prostaglandin F receptor, Science, 277, 681, 10.1126/science.277.5326.681
Cirino, 1998, Multiple controls in inflammation. Extracellular and intracellular phospholipase A2, inducible and constitutive cyclooxygenase, and inducible nitric oxide synthase, Biochem Pharmacol, 55, 105, 10.1016/S0006-2952(97)00215-3
Appleton, 1993, Temporal and spatial immunolocalization of cytokines in murine chronic granulomatous tissue. Implications for their role in tissue development and repair processes, Lab Invest, 69, 405
Perretti, 1993, Pharmacology of interleukin-1-induced neutrophil migration, Agents Actions, 38 Spec No, C64, 10.1007/BF01991139
Vane, 1994, Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation, Proc Natl Acad Sci USA, 91, 2046, 10.1073/pnas.91.6.2046
Futaki, 1993, Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation, J Pharm Pharmacol, 45, 753, 10.1111/j.2042-7158.1993.tb07103.x
Futaki, 1994, NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro, Prostaglandins, 47, 55, 10.1016/0090-6980(94)90074-4
Wallace, 1998, Cyclooxygenase 1 contributes to inflammatory responses in rats and mice, Gastroenterology, 115, 101, 10.1016/S0016-5085(98)70370-1
Mizuno, 1997, Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice, Gastroenterology, 112, 387, 10.1053/gast.1997.v112.pm9024292
Bozza, 1996, Leukocyte lipid body formation and eicosanoid generation, Proc Natl Acad Sci USA, 93, 11091, 10.1073/pnas.93.20.11091
Whittle, 1992, Biosynthesis and role of the endothelium-derived vasodilator, nitric oxide, in the gastric mucosa, Ann NY Acad Sci, 664, 126, 10.1111/j.1749-6632.1992.tb39755.x
Price, 1990, Mechanisms of NSAID-induced gastroenteropathy, Drugs, 40, 1, 10.2165/00003495-199000405-00003
Lee, 1992, Importance of gastric acid in gastric ulcer formation in rabbits with antibody-induced prostaglandin deficiency, Gastroenterology, 103, 1467, 10.1016/0016-5085(92)91166-2
Smith, 1998, The pharmacology of the ductus arteriosus, Pharmacol Rev, 50, 35
Momma, 1985, Characteristic morphology of the constricted fetal ductus arteriosus following maternal administration of indomethacin, Pediatr Res, 19, 493, 10.1203/00006450-198505000-00017
Moise, 1993, Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use, Am J Obstet Gynecol, 168, 1350, 10.1016/S0002-9378(11)90763-7
Nguyen, 1997, The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth, Nature, 390, 78, 10.1038/36342
Segi, 1998, Patent ductus arteriosus and neonatal death in prostaglandin receptor EP4-deficient mice, Biochem Biophys Res Commun, 246, 7, 10.1006/bbrc.1998.8461
Matijevic-Aleksic, 1996, Bleeding disorder due to platelet prostaglandin H synthase-1 (PGHS-1) deficiency, Br J Haematol, 92, 212, 10.1046/j.1365-2141.1996.279813.x
Shibata, 1997, Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene, Science, 278, 120, 10.1126/science.278.5335.120